A 'cure' for Down syndrome: What do parents want?

Clinical Genetics

Volumn 86, Issue 4, 2014, Pages 310-317

  Inglis, A ^a   Lohn, Z ^b   Austin, Jehannine C ^a   Hippman, Catriona ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Attitudes; Cure; Down syndrome; Intellectual disability; Parents; Therapeutics

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; DOWN SYNDROME; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INDEPENDENCE; LONG TERM CARE; MALE; MEDICAL ETHICS; MEDICAL SOCIETY; MOTIVATION; PARENTAL ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; STIGMA; BRITISH COLUMBIA; CHILD; GENE THERAPY; GENETICS; INTELLECTUAL DISABILITY; PARENT; PSYCHOLOGY;

BRITISH COLUMBIA; CANADA; CHILD; DOWN SYNDROME; GENETIC THERAPY; HUMANS; INTELLECTUAL DISABILITY; PARENTS; SURVEYS AND QUESTIONNAIRES;

EID: 84908244597     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12364     Document Type: Article

References (38)

1. Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 2010: 9 (6): 623-633.
2. Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D. Effects of donepezil on cognitive functioning in Down syndrome. Am J Ment Retard 2003: 108 (6): 367-372.
3. Heller JH, Spiridigliozzi GA, Sullivan JA, Doraiswamy PM, Krishnan RR, Kishnani PS. Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial. Am J Med Genet A 2003: 116A (2): 111-116.
4. Heller JH, Spiridigliozzi GA, Doraiswamy PM, Sullivan JA, Crissman BG, Kishnani PS. Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. AmJMed Genet A 2004: 130A (3): 325-326.
5. Spiridigliozzi GA, Heller JH, Crissman BG et al. Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series. Am J Med Genet A 2007: 143A (13): 1408-1413.
6. Kishnani PS, Heller JH, Spiridigliozzi GA et al. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17. Am J Med Genet A 2010: 152A (12): 3028-3035.
7. Liu C, Belichenko PV, Zhang L et al. Mouse models for Down syndrome-associated developmental cognitive disabilities. Dev Neurosci 2011: 33 (5): 404-413.
8. Haydar TF, Reeves RH. Trisomy 21 and early brain development. Trends Neurosci 2012: 35 (2): 81-91.
9. Incerti M, Toso L, Vink J et al. Prevention of learning deficit in a Down syndrome model. Obstet Gynecol 2011: 117 (2 Pt 1): 354-361.
10. Ruparelia A, Pearn ML, Mobley WC. Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome. Curr Opin Neurobiol 2012: 22 (5): 880-886.
11. Kleschevnikov AM, Belichenko PV, Gall J et al. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis 2012: 45 (2): 683-691.
12. Kleschevnikov AM, Belichenko PV, Faizi M et al. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. J Neurosci 2012: 32 (27): 9217-9227.
13. Das I, Park JM, Shin JH et al. Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci Transl Med 2013: 5 (201): 201ra120.
14. Jiang J, Jing Y, Cost GJ et al. Translating dosage compensation to trisomy 21. Nature 2013.
15. Fidler D, Hodapp R, Dykens E. Stress in families of young children with Down syndrome, Williams syndrome, and Smith-Magenis syndrome. Early Educ Dev 2000: 11 (4): 395-406.
16. Abbeduto L, Seltzer MM, Shattuck P, Krauss MW, Orsmond G, Murphy MM. Psychological well-being and coping in mothers of youths with autism, Down syndrome, or Fragile X syndrome. Am J Ment Retard 2004: 109 (3): 237-254.
17. Blacher J, McIntyre LL. Syndrome specificity and behavioural disorders in young adults with intellectual disability: cultural differences in family impact. J Intellect Disabil Res 2006: 50 (Pt 3): 184-198.
18. Most DE, Fidler DJ, Booth-LaForce C, Kelly J. Stress trajectories in mothers of young children with Down syndrome. J Intellect Disabil Res 2006: 50 (Pt 7): 501-514.
19. Skotko BG, Levine SP, Goldstein R. Having a son or daughter with Down syndrome: perspectives from mothers and fathers. Am J Med Genet A 2011: 155A (10): 2335-2347.
20. Edwards SD. Prevention of disability on grounds of suffering. J Med Ethics 2001: 27 (6): 380-382.
21. Prussing E, Sobo EJ, Walker E, Kurtin PS. Between 'desperation' and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome. Soc Sci Med 2005: 60 (3): 587-598.
22. Hippman C, Inglis A, Austin J. What is a "balanced" description? Insight from parents of individuals with Down syndrome. J Genet Couns 2012: 21 (1): 35-44.
23. Inglis A, Hippman C, Austin JC. Prenatal testing for Down syndrome: the perspectives of parents of individuals with Down syndrome. Am J Med Genet A 2012: 158A (4): 743-750.
24. Neergaard MA, Olesen F, Andersen RS, Sondergaard J. Qualitative description - the poor cousin of health research? BMC Med Res Methodol 2009: 9: 52.
25. Rapp R, Ginsburg F. Enabling disability: rewriting kinship, reimagining citizenship. Public Cult 2001: 13 (3): 533-556.
26. Rapp R. Amniocentesis in sociocultural perspective. J Genet Couns 1993: 2 (3): 183-196.
27. Pillay D, Girdler S, Collins M, Leonard H. "It's not what you were expecting, but it's still a beautiful journey": the experience of mothers of children with Down syndrome. Disabil Rehabil 2012: 34 (18): 1501-1510.
28. Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V. Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2012: 22 (3): 226-237.
29. Landsman G. Emplotting children's lives: developmental delay vs. disability. Soc Sci Med 2003: 56 (9): 1947-1960.
30. King G, Baxter D, Rosenbaum P, Zwaigenbaum L, Bates A. Belief systems of families of children with autism spectrum disorders or Down syndrome. Hammill Institute on Disabilities 2009: 24 (1): 50-64.
31. Skotko BG, Levine SP, Goldstein R. Having a brother or sister with Down syndrome: perspectives from siblings. Am J Med Genet A 2011: 155A (10): 2348-2359.
32. Povee K, Roberts L, Bourke J, Leonard H. Family functioning in families with a child with Down syndrome: a mixed methods approach. J Intellect Disabil Res 2012: 56 (10): 961-973.
33. Cunningham C, Glenn S. Self-awareness in young adults with Down syndrome: I. awareness of Down syndrome and disability. Int J Disabil Dev Educ 2004: 51 (4): 335-361.
34. Skotko BG, Levine SP, Goldstein R. Self-perceptions from people with Down syndrome. Am J Med Genet A 2011: 155A (10): 2360-2369.
35. Siklos S, Kerns KA. Assessing need for social support in parents of children with autism and Down syndrome. J Autism Dev Disord 2006: 36 (7): 921-933.
36. Phelps RA, Pinter JD, Lollar DJ, Medlen JG, Bethell CD. Health care needs of children with Down syndrome and impact of health system performance on children and their families. J Dev Behav Pediatr 2012: 33 (3): 214-220.
37. Hagerman R, Lauterborn J, Au J, Berry-Kravis E. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ 2012: 54: 297-335.
38. Wetmore DZ, Garner CC. Emerging pharmacotherapies for neurodevelopmental disorders. J Dev Behav Pediatr 2010: 31 (7): 564-581.